Oral postmenopausal hormone therapy and genetic risk on venous thromboembolism: gene-hormone interaction results from a large prospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Menopause"
DOI: 10.1097/gme.0000000000001924
Abstract: Abstract Objective: Oral postmenopausal hormone therapy (HT) has been shown to be associated with venous thromboembolism (VTE), but whether this association is modified by VTE-associated genetic susceptibility is unknown. We examined interactions between oral HT… read more here.
Keywords: grs; vte; oral postmenopausal; risk ... See more keywords